Avoro Capital Advisors LLC - Insider Trading & Ownership
Location
110 Greene Street, Suite 800, New York, NY
Summary
The estimated value of insider holdings of Avoro Capital Advisors LLC is at least $10M dollars as of September 14, 2023. Avoro Capital Advisors LLC is the 10%+ Owner of CymaBay Therapeutics, Inc. and owns shares of CymaBay Therapeutics, Inc. stock worth about $10M.
Signature
Avoro Capital Advisors LLC, by: /s/ Scott Epstein, its Chief Financial Officer & Chief Compliance Officer
Insider Transactions Reported by Avoro Capital Advisors LLC:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.